top of page

TRANSACTIONS & NEWS

Cellular Biomedicine Group Announces Exclusive Collaboration and License Agreement with Janssen to Develop and Commercialize anti CD19 & CD20 Bi-Specific and anti CD20 CAR-Ts for Non-Hodgkin Lymphoma

May 3, 2023 at 1:25:57 AM

View More

Sherwin-Williams Signs Agreement to Divest China Architectural Paint Business to Akzo Nobel N.V.

April 25, 2023 at 12:33:00 AM

View More

China's Biem.L.Fdlkk Rises on USD103.4 Million Deal for Cerruti 1881, Kent & Curwen

April 6, 2023 at 3:15:40 AM

View More

BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors

April 3, 2023 at 1:04:05 PM

View More

Baijiayun to Acquire Beijing Hydrogen, an AI-enabled Marketing Service Provider in China

April 3, 2023 at 2:55:23 AM

View More

TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China

March 29, 2023 at 1:04:23 AM

View More
bottom of page